5-[6-acetyl-7-amino-3-(1-phenylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]pyridine-3-carboxylic acid;6-bromo-5-(4-methylsulfinylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(4-methylsulfonylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine
C119H85Br2N29O16S4 — CID 159968081
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[6-acetyl-7-amino-3-(1-phenylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]pyridine-3-carboxylic acid;6-bromo-5-(4-methylsulfinylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(4-methylsulfonylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine
5-[6-acetyl-7-amino-3-(1-phenylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]pyridine-3-carboxylic acid;6-bromo-5-(4-methylsulfinylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(4-methylsulfonylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine (PubChem CID 159968081) has the molecular formula C119H85Br2N29O16S4 and a molecular weight of 2465.25 g/mol. Its IUPAC name is 5-[6-acetyl-7-amino-3-(1-phenylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]pyridine-3-carboxylic acid;6-bromo-5-(4-methylsulfinylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(4-methylsulfonylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine.
Molecular Properties
| Compound Name | 5-[6-acetyl-7-amino-3-(1-phenylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]pyridine-3-carboxylic acid;6-bromo-5-(4-methylsulfinylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(4-methylsulfonylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine |
|---|---|
| PubChem CID | 159968081 |
| Molecular Formula | C119H85Br2N29O16S4 |
| Molecular Weight | 2465.25 g/mol |
| Exact Mass | 2461.40 |
| IUPAC Name | 5-[6-acetyl-7-amino-3-(1-phenylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one;5-[6-acetyl-7-amino-3-(6-phenyl-3-pyridinyl)pyrazolo[1,5-a]pyrimidin-5-yl]pyridine-3-carboxylic acid;6-bromo-5-(4-methylsulfinylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-(4-methylsulfonylphenoxy)-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine |
| SMILES | CC(=O)c1c(-c2ccc3c(c2)C(=O)NS3(=O)=O)nc2c(-c3ccc(-c4ccccc4)nc3)cnn2c1N.CC(=O)c1c(-c2ccc3c(c2)C(=O)NS3(=O)=O)nc2c(-c3cnn(-c4ccccc4)c3)cnn2c1N.CC(=O)c1c(-c2cncc(C(=O)O)c2)nc2c(-c3ccc(-c4ccccc4)nc3)cnn2c1N.CS(=O)(=O)c1ccc(Oc2nc3c(-c4cnc5ccccc5c4)cnn3c(N)c2Br)cc1.CS(=O)c1ccc(Oc2nc3c(-c4cnc5ccccc5c4)cnn3c(N)c2Br)cc1 |
| InChI | InChI=1S/C26H18N6O4S.C25H18N6O3.C24H17N7O4S.C22H16BrN5O3S.C22H16BrN5O2S/c1-14(33)22-23(16-8-10-21-18(11-16)26(34)31-37(21,35)36)30-25-19(13-29-32(25)24(22)27)17-7-9-20(28-12-17)15-5-3-2-4-6-15;1-14(32)21-22(17-9-18(25(33)34)11-27-10-17)30-24-19(13-29-31(24)23(21)26)16-7-8-20(28-12-16)15-5-3-2-4-6-15;1-13(32)20-21(14-7-8-19-17(9-14)24(33)29-36(19,34)35)28-23-18(11-27-31(23)22(20)25)15-10-26-30(12-15)16-5-3-2-4-6-16;1-32(29,30)16-8-6-15(7-9-16)31-22-19(23)20(24)28-21(27-22)17(12-26-28)14-10-13-4-2-3-5-18(13)25-11-14;1-31(29)16-8-6-15(7-9-16)30-22-19(23)20(24)28-21(27-22)17(12-26-28)14-10-13-4-2-3-5-18(13)25-11-14/h2-13H,27H2,1H3,(H,31,34);2-13H,26H2,1H3,(H,33,34);2-12H,25H2,1H3,(H,29,33);2-12H,24H2,1H3;2-12H,24H2,1H3 |
| InChIKey | OEEQSHQDMBTTAY-UHFFFAOYSA-N |
| XLogP | 19.12 |
| TPSA | 647.98 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 170 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2465.25 |
| LogP ≤ 5 | 19.12 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 42 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159968081 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.